Segmentation Robustness and Predictive Utility in Glioblastoma Radiomics: Evidence for a Trade-off in Survival Modelling

• URL: http://arxiv.org/abs/2607.23626v1
• Date: Sun, 26 Jul 2026 12:20:08 GMT
• Title: Segmentation Robustness and Predictive Utility in Glioblastoma Radiomics: Evidence for a Trade-off in Survival Modelling
• Abstract summary: Radiomic biomarkers have been widely investigated as non-invasive tools for tumor characterization and prognostic modeling in glioblastoma (GBM)<n>In this study, we investigate the relationship between feature robustness and predictive utility in GBM survival modeling.<n>Findings suggest that robustness alone is not a reliable criterion for feature selection in radiomics-based survival modelling.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Radiomic biomarkers derived from magnetic resonance imaging (MRI) have been widely investigated as non-invasive tools for tumor characterization and prognostic modeling in glioblastoma (GBM). However, their clinical translation remains limited, in part due to sensitivity to tumor segmentation variability. In this study, we systematically investigate the relationship between feature robustness and predictive utility in GBM survival modeling using the University of Pennsylvania Glioblastoma Imaging, Genomics, and Radiomics (UPENN-GBM) cohort. A total of 4,752 radiomic features were obtained from multiparametric MRI across three tumor subregions: enhancing tumor (ET), peritumoral edema (ED), and necrotic core (NC). Feature robustness was quantified using the intraclass correlation coefficient (ICC) based on the automatic and expert-refined segmentation versions. Among features with valid ICC estimates, 48.1% were classified as robust. Survival prediction was evaluated using cross-validation with Coxnet, Random Survival Forest, and Gradient Boosting Survival Analysis models. In this cohort, radiomic feature inclusion showed no consistent improvement over the clinical baseline, and robustness filtering produced no detectable performance gain. Model-selected features were less robust than the overall feature pool, indicating a lack of enrichment for robustness. These findings suggest that robustness alone is not a reliable criterion for feature selection in radiomics-based survival modelling.

Related papers

• Predictive Radiomics for Evaluation of Cancer Immune SignaturE in Glioblastoma: the PRECISE-GBM study [5.798780829165377]
  Radiogenomic models non-invasively predicted the macrophage subtype M0 immune signature in IDH-wildtype glioblastoma.<n>These biomarkers have the potential to stratify patients for immunotherapy within prospective glioblastoma clinical trials.
  arXiv  Detail & Related papers  (2026-05-11T09:38:40Z)
• DRBD-Mamba for Robust and Efficient Brain Tumor Segmentation with Analytical Insights [54.87947751720332]
  Accurate brain tumor segmentation is significant for clinical diagnosis and treatment.<n>Mamba-based State Space Models have demonstrated promising performance.<n>We propose a dual-resolution bi-directional Mamba that captures multi-scale long-range dependencies with minimal computational overhead.
  arXiv  Detail & Related papers  (2025-10-16T07:31:21Z)
• Prediction of Distant Metastasis for Head and Neck Cancer Patients Using Multi-Modal Tumor and Peritumoral Feature Fusion Network [6.753955554949766]
  Metastasis remains the major challenge in the clinical management of head and neck squamous cell carcinoma (HN SCC)<n>This study develops a deep learning-based framework to predict metastasis risk in HN SCC patients by integrating computed tomography (CT) images, radiomics, and clinical data.
  arXiv  Detail & Related papers  (2025-08-28T06:39:38Z)
• LGE-Guided Cross-Modality Contrastive Learning for Gadolinium-Free Cardiomyopathy Screening in Cine CMR [51.11296719862485]
  We propose a Contrastive Learning and Cross-Modal alignment framework for gadolinium-free cardiomyopathy screening using cine CMR sequences.<n>By aligning the latent spaces of cine CMR and Late Gadolinium Enhancement (LGE) sequences, our model encodes fibrosis-specific pathology into cine CMR embeddings.
  arXiv  Detail & Related papers  (2025-08-23T07:21:23Z)
• Radiomic fingerprints for knee MR images assessment [39.11295870085984]
  Existing radiomic approaches use a fixed set of radiomic features, selected at the population level and applied uniformly to all patients.<n>While interpretable, these signatures are often too constrained to represent individual pathological variations.<n>We propose a novel radiomic fingerprint framework, in which a radiomic feature set (the fingerprint) is dynamically constructed for each patient, selected by a DL model.<n>Unlike the existing radiomic signatures, our fingerprints are derived on a per-patient basis by predicting the feature relevance in a large radiomic feature pool, and selecting only those that are predictive of clinical conditions for individual patients.
  arXiv  Detail & Related papers  (2025-06-25T10:39:22Z)
• CT Radiomics-Based Explainable Machine Learning Model for Accurate Differentiation of Malignant and Benign Endometrial Tumors: A Two-Center Study [11.010138196822888]
  We developed a CT radiomics-based explainable machine learning model for precise diagnosing malignancy and benignity in endometrial cancer patients.<n>The diagnostic performance of the model was evaluated by using sensitivity, specificity, accuracy, precision, F1 score, AUROC, and AUPRC.<n>The Random Forest model emerged as the optimal choice for diagnosing EC, with a training AUROC of 1.00 and a testing AUROC of 0.96.
  arXiv  Detail & Related papers  (2025-06-22T17:31:06Z)
• Exploring Kinetic Curves Features for the Classification of Benign and Malignant Breast Lesions in DCE-MRI [3.3382992386198675]
  We propose to leverage the dynamic characteristics from the kinetic curves as well as the radiomic features to boost the classification accuracy of benign and malignant breast lesions. The proposed method is evaluated on an in-house dataset including 200 DCE-MRI scans with 298 breast tumors.
  arXiv  Detail & Related papers  (2024-04-22T07:08:13Z)
• Improved Prognostic Prediction of Pancreatic Cancer Using Multi-Phase CT by Integrating Neural Distance and Texture-Aware Transformer [37.55853672333369]
  This paper proposes a novel learnable neural distance that describes the precise relationship between the tumor and vessels in CT images of different patients. The developed risk marker was the strongest predictor of overall survival among preoperative factors.
  arXiv  Detail & Related papers  (2023-08-01T12:46:02Z)
• Deep learning-based approach to reveal tumor mutational burden status from whole slide images across multiple cancer types [41.61294299606317]
  Tumor mutational burden (TMB) is a potential genomic biomarker of immunotherapy. TMB detected through whole exome sequencing lacks clinical penetration in low-resource settings. In this study, we proposed a multi-scale deep learning framework to address the detection of TMB status from routinely used whole slide images.
  arXiv  Detail & Related papers  (2022-04-07T07:02:32Z)
• Adaptive unsupervised learning with enhanced feature representation for intra-tumor partitioning and survival prediction for glioblastoma [12.36330256366686]
  We propose an adaptive unsupervised learning approach for efficient MRI intra-tumor partitioning and glioblastoma survival prediction. A novel and problem-specific Feature-enhanced Auto-Encoder (FAE) is developed to enhance the representation of pairwise clinical modalities. The results demonstrate that the proposed approach can produce robust and clinically relevant MRI sub-regions and statistically significant survival predictions.
  arXiv  Detail & Related papers  (2021-08-21T02:47:59Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.